Your browser doesn't support javascript.
loading
FLT4 as a marker for predicting prognostic risk of refractory acute myeloid leukemia.
Lee, Ji Yoon; Lee, Sung-Eun; Han, A-Reum; Lee, Jongeun; Yoon, Young-Sup; Kim, Hee-Je.
Affiliation
  • Lee JY; Leukemia Research Institute, College of Medicine, The Catholic University of Korea, Seoul, Korea; Severance Biomedical Science Institute, Yonsei University College of Medicine, Seoul.
  • Lee SE; Catholic Hematology Hospital, Seoul St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Seoul.
  • Han AR; Leukemia Research Institute, College of Medicine, The Catholic University of Korea, Seoul.
  • Lee J; Severance Biomedical Science Institute, Yonsei University College of Medicine, Seoul.
  • Yoon YS; Severance Biomedical Science Institute, Yonsei University College of Medicine, Seoul, Korea; Department of Medicine, Emory University. yyoon5@emory.edu.
  • Kim HJ; Leukemia Research Institute, College of Medicine, The Catholic University of Korea, Seoul, Korea; Catholic Hematology Hospital, Seoul St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Seoul. cumckim@catholic.ac.kr.
Haematologica ; 108(11): 2933-2945, 2023 11 01.
Article in En | MEDLINE | ID: mdl-37317880

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Leukemia, Myeloid, Acute / Antineoplastic Agents Type of study: Etiology_studies / Prognostic_studies / Risk_factors_studies Limits: Animals / Humans Language: En Journal: Haematologica Year: 2023 Document type: Article

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Leukemia, Myeloid, Acute / Antineoplastic Agents Type of study: Etiology_studies / Prognostic_studies / Risk_factors_studies Limits: Animals / Humans Language: En Journal: Haematologica Year: 2023 Document type: Article